Evolent Health (EVH) Operating Expenses (2015 - 2026)

Evolent Health has reported Operating Expenses for 12 years, with the latest figure at $662.1 million in Q2 2026.

• On a quarterly basis, Operating Expenses rose 48.62% year-over-year to $662.1 million in Q2 2026; TTM through Jun 2026 was $2.5 billion, a 13.03% increase from a year earlier, with the FY2025 full-year figure at $2.3 billion, down 11.9% from the prior year.
• Operating Expenses was $662.1 million for Q2 2026 at Evolent Health, up from $506.8 million in the prior quarter.
• The five-year high for Operating Expenses was $877.0 million in Q4 2025, with the low at $299.9 million in Q1 2022.
• Average Operating Expenses over 5 years is $524.1 million, with a median of $498.8 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Operating Expenses soared 55.74% in 2023, then sank 30.32% in 2025.
• Over 5 years, Operating Expenses stood at $384.3 million in 2022, then jumped by 50.24% to $577.4 million in 2023, then advanced by 15.19% to $665.1 million in 2024, then jumped by 31.84% to $877.0 million in 2025, then slipped by 24.5% to $662.1 million in 2026.
• The last three Operating Expenses figures came in at $662.1 million (Q2 2026), $506.8 million (Q1 2026), and $877.0 million (Q4 2025), per Business Quant data.